Display options
Share it on

Front Neurosci. 2016 May 03;10:187. doi: 10.3389/fnins.2016.00187. eCollection 2016.

Metabolic Covariant Network in Relation to Nigrostriatal Degeneration in Carbon Monoxide Intoxication-Related Parkinsonism.

Frontiers in neuroscience

Chiung-Chih Chang, Jung-Lung Hsu, Wen-Neng Chang, Shu-Hua Huang, Chi-Wei Huang, Ya-Ting Chang, Nai-Ching Chen, Chun-Chung Lui, Chen-Chang Lee, Shih-Wei Hsu

Affiliations

  1. Department of Neurology, Cognition and Aging Center, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine Kaohsiung, Taiwan.
  2. Section of Dementia and Cognitive Impairment, Department of Neurology, Chang Gung Memorial HospitalLinkou, Taiwan; Graduate Institute of Humanities in Medicine, Taipei Medical UniversityTaipei, Taiwan.
  3. Department of Nuclear Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine Kaohsiung, Taiwan.
  4. Department of Radiology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine Kaohsiung, Taiwan.

PMID: 27199649 PMCID: PMC4853409 DOI: 10.3389/fnins.2016.00187

Abstract

Presence of parkinsonian features after carbon monoxide (CO) intoxication is well known and the severity was found to relate to the pre-synaptic dopaminergic deficits. There is no systemic study to analyse the functional network involved in CO-related Parkinsonism. Forty-five CO-related parkinsonism patients and 25 aged-matched controls completed the 3D T1-weighted imaging and (18)F-fluoro-2-deoxyglucose positron emission tomography (FDG-PET). Voxel-based morphometry (VBM) was performed to assess the structural and functional brain differences between the patients and controls. Spatial covariant networks responsible for distinguishing patients and controls were constructed using independent component analysis. For validation, the pre-synaptic dopaminergic functional network was established by regression model using striatal TRODAT-1 SPECT as the independent variable. The clinical significance of both networks was determined by correlation with the Unified Parkinson's Disease Rating Scale (UPDRS). Compared with controls, the spatial covariant signals of FDG-PET were significantly lower in the medial and lateral frontal, caudate nucleus, dorsomedial prefrontal areas, and temporal-parietal regions while the spatial intensities correlated significantly with UPDRS total scores. The functional network that correlated with striatum pre-synaptic dopaminergic uptakes included the midbrain, thalamus, caudate, lateral frontal cortex, ventral striatum, ventral, or dorsal anterior cingulate cortex. Both networks overlapped considerably and the topographies reflected structural damage pattern. Our study provides evidence that glucose metabolism in CO-parkinsonism patients pertains to an organized covariant pattern in the cortical regions that is spatially coherent with the cortical map of pre-synaptic dopamine deficits. As the fronto-temporal, striatum, and temporal-parietal areas were involved, the unique metabolic covariant network suggests a different pathophysiology in CO-related parkinsonism.

Keywords: carbon monoxide intoxication; metabolic covariant network; nigra-striatal degeneration; parkinsonian symptoms; pre-synaptic dopamine deficit

References

  1. J Cereb Blood Flow Metab. 1994 Sep;14 (5):783-801 - PubMed
  2. Eur Neurol. 2002;48(1):30-3 - PubMed
  3. Crit Care Clin. 1999 Apr;15(2):297-317, viii - PubMed
  4. Neurology. 1998 Sep;51(3):803-10 - PubMed
  5. Arch Neurol. 1982 May;39(5):302-4 - PubMed
  6. PLoS Med. 2014 Apr 01;11(4):e1001622 - PubMed
  7. Proc Natl Acad Sci U S A. 2010 Mar 9;107(10):4734-9 - PubMed
  8. Brain. 2011 Dec;134(Pt 12):3632-46 - PubMed
  9. Neuroimage. 2011 Jan 15;54(2):1244-53 - PubMed
  10. Prog Brain Res. 1967;24:31-74 - PubMed
  11. Neurotoxicology. 2010 Aug;31(4):403-7 - PubMed
  12. Brain. 1995 Feb;118 ( Pt 1):279-306 - PubMed
  13. Brain Inj. 2006 Mar;20(3):273-81 - PubMed
  14. Acta Neurol Taiwan. 2012 Mar;21(1):44-8 - PubMed
  15. Mov Disord. 2008 Apr 15;23 (5):727-33 - PubMed
  16. Eur J Neurol. 2009 Oct;16(10):1144-50 - PubMed
  17. J Cereb Blood Flow Metab. 1984 Dec;4(4):484-99 - PubMed
  18. Mov Disord. 2010 Jul 30;25(10):1513-5 - PubMed
  19. J Cereb Blood Flow Metab. 1992 Jul;12 (4):571-83 - PubMed
  20. Arch Neurol. 1983 Jul;40(7):433-5 - PubMed
  21. Neuroradiology. 2013 Jan;55(1):107-15 - PubMed
  22. Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4637-42 - PubMed
  23. Trends Neurosci. 2009 Oct;32(10 ):548-57 - PubMed
  24. Arch Neurol. 1983 Jul;40(7):443-4 - PubMed
  25. Medicine (Baltimore). 2015 May;94(19):e783 - PubMed
  26. Clin Neurol Neurosurg. 1987;89(4):275-9 - PubMed
  27. Brain Struct Funct. 2013 May;218(3):697-709 - PubMed
  28. J Neurosci. 2007 Feb 28;27(9):2349-56 - PubMed
  29. Arch Intern Med. 1962 Jul;110:18-25 - PubMed
  30. Neuroimage. 2002 Jan;15(1):273-89 - PubMed
  31. Eur J Neurol. 2015 May;22(5):845-52, e59-60 - PubMed
  32. Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):2563-8 - PubMed
  33. Am J Psychiatry. 1976 Mar;133(3):317-20 - PubMed
  34. Lancet Neurol. 2007 Oct;6(10):926-32 - PubMed
  35. Clin Nucl Med. 2015 Jan;40(1):26-31 - PubMed
  36. Arch Neurol. 2000 Aug;57(8):1214-8 - PubMed
  37. J Comp Neurol. 1986 Oct 1;252(1):106-29 - PubMed
  38. Magn Reson Med. 1995 Oct;34(4):537-41 - PubMed

Publication Types